Actively Recruiting

Phase Not Applicable
Age: 18Years - 100Years
All Genders
NCT06304779

The Effect of Continuous Intravenous Infusion of Lidocaine on PPCs and Prognosis in Emergency Surgical Patients With IAI

Led by Shanghai Zhongshan Hospital · Updated on 2026-04-29

428

Participants Needed

1

Research Sites

213 weeks

Total Duration

On this page

Sponsors

S

Shanghai Zhongshan Hospital

Lead Sponsor

T

The Affiliated Hospital of Xuzhou Medical University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The main purpose of this study is to evaluate the impact of continuous 24-hour intravenous infusion of lidocaine on the incidence of PPCs in patients undergoing emergency laparotomy for intra-abdominal infection (IAI).The secondary objectives of this study are to assess the impact of continuous 24-hour intravenous lidocaine infusion on the proportion of patients requiring mechanical ventilation, protection of important organ function during the perioperative period, length of hospital stay, and outcomes within 30 days postoperatively.

CONDITIONS

Official Title

The Effect of Continuous Intravenous Infusion of Lidocaine on PPCs and Prognosis in Emergency Surgical Patients With IAI

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age >18 years, any gender
  • Patients suspected of digestive tract perforation or obstruction confirmed by imaging, requiring emergency surgery
  • Planned use of general anesthesia for surgery
  • Patient or family has read and signed informed consent
  • Evidence of inflammation such as elevated serum procalcitonin, leukocytosis (>12×10^9/L), leukopenia (<4×10^9/L), or >10% naive leukocytes
Not Eligible

You will not qualify if you...

  • History of allergy to local anesthetic drugs
  • Pregnant patients
  • Receiving renal replacement therapy
  • Having arrhythmias or heart failure (second or third-degree atrioventricular block or reduced left ventricular ejection fraction)
  • Preoperative platelet count <80 × 10^9/L
  • Need for secondary surgery due to postoperative anastomotic fistula
  • Participation in other clinical studies

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zhongshan Hospital,Fudan university

Shanghai, Shanghai Municipality, China, 200032

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here